Rua Bioscience

Rua is a New Zealand cannabis pharmaceutical company that is aiming to be a leading producer of cannabinoid derived medicines. The Company was established in 2017 in part to support local economic development in the Tairawhiti (East Coast) region, and is a pioneer in the New Zealand medicinal cannabis sector. It was the first company in New Zealand to obtain a licence to cultivate cannabis for research purposes. Rua will operate in the research, cultivation, extraction and manufacturing parts of the medicinal cannabis supply chain.


Company Details

Registered Office: 1 Commerce Place, Awapuni, Gisborne 4071
Postal Address: 1 Commerce Place, Awapuni, Gisborne 4071
Telephone: +64-6-390-6938
Facsimile: n/a
Website: www.ruabio.com
First Listed: 22/10/2020
Balance Date: 30 June
AGM: 12/10/2022

Directors and Executives

Tony Barclay
Independent Director
Panapa Ehau
Executive Director
Teresa Farac-Ciprian Independent Non-Executive Director
Brett Gamble
Non-Executive Director
Paul Naske
Chief Executive Officer
Anna Stove
Chair
Hamish White
Chief Financial Officer

Announcements

Title Date Type
Record Sales in March for New Zealand Mon, Mar 31 2025 08:30 am MKTUPDTE
Rua Bioscience Half Year Results data Mon, Mar 03 2025 08:30 am GENERAL
Rua Bioscience Half Year Results - Global Growth Fri, Feb 28 2025 08:30 am HALFYR
Capital Change Notice Fri, Feb 14 2025 10:24 am SECISSUE
Revenue exceeds previous forecast Tue, Jan 28 2025 09:13 am MKTUPDTE
Revenue exceeds previous forecast Tue, Jan 28 2025 08:57 am MKTUPDTE
Psilocybin clinical trial update Tue, Jan 21 2025 01:29 pm MKTUPDTE
Capital Change Notice Mon, Jan 06 2025 12:33 pm SECISSUE
Capital Change Notice Tue, Dec 31 2024 12:24 pm OFFER
Rua Bioscience announces launch of new products in the UK Thu, Dec 19 2024 11:20 am MKTUPDTE

Major Holdings Announcements

Date Name No. Held % Current
22/12/22 Michael John Wilding 8,509,556 - 5.39
18/03/22 Hikurangi Enterprises Limited 8,132,620 - 5.43
17/03/22 Hikurangi Bioactives Limited Partne 4,000,000 12.58 2.67
22/10/20 Tailorspace Capital Limited, Tailor 11,129,375 - 7.95
22/10/20 Fang Group Investment Limited and F 23,584,939 - 16.85
22/10/20 Andrew Charles Williams 7,756,838 - 5.54

Director’s Interests Announcements

Date Name No. Held % Details Other
31/05/23 Hamish White 80,895 - - -
17/05/23 Antony George Barclay 50,000 - - -
02/11/21 Paul Naske 159,872 - - -
02/11/21 Rob Mitchell 288,251 - - -
02/11/21 Panapa Ehau 474,224 - - -
02/11/21 Trevor Burt 958,002 - - -
22/10/20 Martin Smith 2,544,732 - - -
22/10/20 Brett Gamble 1,805,914 - - -
22/10/20 Anna Stove 763,896 - - -

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 06/06/2023


Markets News

Markets Market Close

Gentrack leads NZ sharemarket down almost 1%

The S&P/NZX 50 Index closed at 12,225.28, down 113.29 points or 0.92%.

Graham Skellern 04 Apr 2025
Gentrack leads NZ sharemarket down almost 1%
Markets

Asian stocks extend global rout

Tokyo shares fall as Trump predicts a coming US boom.

AFP 04 Apr 2025
Asian stocks extend global rout
Retail

KMD Brands pulled into Trump trade war

Like a lot associated with so-called ‘Liberation Day’, much remains uncertain.

Gregor Thompson 04 Apr 2025
KMD Brands pulled into Trump trade war
Economy

US tariff risk less than expected for FPH, Jarden says

Jarden says tariff-related impacts on earnings would be "nominal" by 2030.

John Anthony 04 Apr 2025
US tariff risk less than expected for FPH, Jarden says